AAWH · Ascend Wellness Holdings, Inc.
Market Cap
$87.50M
Shares
203.21M
AAWH metrics
63 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.43
Market cap
$87.50M
Price action
19 metricsPrice change (1W)
-10.3%
Price change (30D)
+5.9%
Price change (3M)
-27.2%
Price change (6M)
-20.0%
Price change (YTD)
-44.8%
Price change (1Y)
-52.6%
Trailing year
Price change (5Y)
-96.1%
52-week high
$1.08
52-week low
$0.38
Change from 52-week high
-62.9%
Change from 52-week low
+5.9%
Annualized volatility
121.7%
Beta
1.2
RSI (14D)
44.9
Price vs SMA 50
-6.6%
Price vs SMA 200
-25.4%
Avg volume (3M)
55,048
Relative volume
1.3
Average dollar volume
$25,010
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
203.21M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 144.4%
EV / EBITDA
5.3×
reciprocal yield 18.9%
EV / EBIT
—
P / sales
0.2×
reciprocal yield 565.6%
P / book
—
FCF yield
-8.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
5.0
reciprocal yield 20.1%
Earnings yield
-131.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
36.7%
Operating margin
-2.2%
Trailing 12 months
Net margin
-23.3%
Gross profit (TTM)
$179.10M
Operating profit (TTM)
−$10.67M
Net income (TTM)
−$113.83M
Trailing 12 months
Diluted EPS (TTM)
$-0.57
FCF margin
-1.4%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-0.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$488.33M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.4%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.2%
Revenue CAGR (5Y)
+28.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-12.8%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
$64.03M
Free cash flow (TTM)
−$6.95M
Quick ratio
0.9
Interest coverage
-0.2
Net debt / EBITDA
3.9
Return on invested capital
—
Trailing 12 months
Net cash
−$251.82M
Latest balance sheet
Cash & equivalents
$67.00M
Total assets
$888.32M
Total debt
$318.82M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$17.35M
Capital expenditures (TTM)
$24.30M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$2.26M
R&D / revenue
—
Stock compensation / revenue
0.5%
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
37 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—